|Table of Contents|

Clinical observation of CT-guided microwave ablation in 15 cases of recurrent small hepatocellular carcinoma against the diaphragmatic dome

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2018 05
Page:
733-736
Research Field:
Publishing date:

Info

Title:
Clinical observation of CT-guided microwave ablation in 15 cases of recurrent small hepatocellular carcinoma against the diaphragmatic dome
Author(s):
Zhu Chuandong1Ding Huaiyin2Wang Lixue1Xu Hanfeng1Tong Jinlong1Zheng Qin1
1.Deparment of Oncology;2.Department of Radiology,the Second Affiliated Hospital of Southeast University,Jiangsu Nanjing 210003,China.
Keywords:
recurrent small hepatocellular carcinomaradiofrequency ablationcomputer tomography
PACS:
R735.7
DOI:
10.3969/j.issn.1672-4992.2018.05.021
Abstract:
Objective:To retrospectively analyze the clinical efficacy and safety of CT-guided percutaneous microwave ablation (CT-MWA) in the treatment of recurrent small hepatocellular carcinoma (HCC).Methods:A total of 15 patients with recurrent small HCC which against the diaphragmatic dome underwent CT-MWA of clinical data from August 2009 to February 2015 were retrospectively analyzed.To summarize the 1,3-year survival rate,complete ablation rate,local rate of progress,intraoperative and postoperative complications and adverse reactions in the treatment of recurrent small HCC against the diaphragmatic dome.Results:The success rate and complete ablation rate were 93.33% (14/15) and 86.67% (13/15) respectively.The incidence of intraoperative pain was 46.67% (7/15).Postoperative adverse reactions included gastrointestinal reactions (46.67%),liver pain (33.33%),fever (13.33%),abnormal liver function (13.33%).No liver failure,biliary fistula,infection,bleeding and other serious complication,no perioperative death cases.The average survival time was 42 months for 15 patients.The local progression rates of 3 months,6 months,1 year and more than 1 year were 6.67% (1/15),6.67% (1/15),13.33% (2/15) and 13.33% (2/15),respectively.The survival rates of 1 year,2 years and 3 years were 86.67% (13/15),66.67% (10/15) and 46.67% (7/15),respectively.Conclusion:For recurrent small HCC against the diaphragmatic dome,percutaneous CT-MWA is a safe and effective minimally invasive treatment and it is worth to further study with more samples.

References:

[1]Xu Jifan,Luo Shiqiao,Du Bo.Early diagnosis and treatment of recurrment liver cancer[J].Modern Oncology,2017,25(14):2346-2350.[许继凡,罗诗樵,杜波.复发性肝癌的早期诊断及治疗策略[J].现代肿瘤医学,2017,25(14):2346-2350.]
[2]Fukuhara T,Aikata H,Hyogo H,et al.Efficacy of radiofrequency ablation for initial recurrent hepatocellular carcinoma after curative treatment:Comparison with primary cases[J].Eur J Radiol,2015,84(8):1540-1545.
[3]Dodson RM,He J,Pawlik TM.Resection and transplantation for hepatocellular carcinoma:Factors influencing surgical options[J].Future Oncol,2014,10(4):587-607.
[4]Zhang TT,Li KY,Luo HC,et al.Long-term outcomes of percutaneous microwave ablation versus repeat hepatectomy for treatment of late recurrent small hepatocellular carcinoma:A retrospective study[J].National Medical Journal of China,2014,94(33):2570-2572.[张婷婷,李开艳,罗鸿昌,等.经皮微波消融和二次手术治疗晚期复发型小肝癌的长期疗效观察[J].中华医学杂志,2014,94(33):2570-2572.]
[5]Huang J,Yan L,Wu H,et al.Is radiofrequency ablation applicable for recurrent hepatocellular carcinoma after liver transplantation[J]? J Surg Res,2016,200(1):122-130.
[6]Tang T,Gu SZ,Li GW,et al.Ultrasound-guided microwave ablation with artificial pleural effusion for liver tumor adjacent to diaphragmatic dome[J].Journal of Central South University(Medical Science),2017,42(2):184-188.[唐田,古善智,李国文,等.超声引导联合人工胸水微波消融膈顶部肝肿瘤[J].中南大学学报(医学版),2017,42(2): 184-188.]
[7]Liu LN,Xu HX,Lu MD,et al.Percutaneous ultrasound-guided thermal ablation for liver tumor with artificial pleural effusion or ascites[J].Chin J Cancer,2010,29(9):830-835.
[8]Li M,Yu XL,Liang P,et al.Percutaneous microwave ablation for liver cancer adjacent to the diaphragm[J].Int J Hyperthermia,2012,28(3):218-226.
[9]Zytoon AA,Ishii H,Murakami K,et al.Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma.A registry report of the impact of risk factors on outcome[J].Jpn J Clin Oncol,2007,37(9):658-672.
[10]Head HW,Dodd GD,Dalrymple NC,et al.Percutaneous radiofrequency ablation of hepatic tumors against the diaphragm:Frequency of diaphragmatic injury[J].Radiology,2007,243(3):877-884.
[11]Kurokohchi K,Hirai S,Ohgi T,et al.Thoracoscopic ethanol injection and radiofrequency ablation for the treatment of hepatocellular carcinoma located immediately under the diaphragm[J].Int J Oncol,2006,29(2):375-380.
[12]Zhang LH,Zhang CY,Dai XZ,et al.Efficacy of microwave ablation versus remedial hepatectomy for postoperative recurrent small hepatocellular carcinoma[J].Chinese Journal of General Surgery,2015,30(8):631-634.[张立洪,张传永,戴新征,等.术后复发性小肝癌微波消融与再次手术切除的疗效比较[J].中华普通外科杂志,2015,30(8):631-634.]

Memo

Memo:
南京市卫生局一般课题(编号:YKK15141,YKK15142)
Last Update: 1900-01-01